Summary:
Click image to enlarge
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of an new investigational product in subjects with moderately to severely active Ulcerative Colitis.
Qualified Participants Must:
• Between the ages of 18-80
• Have moderately to severely active ulcerative colitis
• Have had an established diagnosis of Ulcerative Colitis for 3 months or more
• Have venous access sufficient to allow blood sampling and medication administration
Qualified Participants May Receive:
- Free consultation at our Hyde Park office
- Compensation for participation and travel
- Travel provided from our Hyde Park office to our Stony Island office
- Travel expenses are reimbursed